Vertex Pharmaceuticals Incorporated
VRTX
$472.83
-$5.06-1.06%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.61B | 6.29B | 6.38B | 6.20B | 6.12B |
| Total Receivables | 2.05B | 1.95B | 1.89B | 1.81B | 1.61B |
| Inventory | 1.69B | 1.63B | 1.50B | 1.36B | 1.21B |
| Prepaid Expenses | 736.20M | 694.50M | 639.90M | 581.60M | 459.20M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 117.10M | 14.90M | 12.40M | 61.20M | 206.50M |
| Total Current Assets | 11.20B | 10.57B | 10.43B | 10.01B | 9.60B |
|
|
|||||
| Total Current Assets | 11.20B | 10.57B | 10.43B | 10.01B | 9.60B |
| Net Property, Plant & Equipment | 3.08B | 3.02B | 2.65B | 2.63B | 2.58B |
| Long-term Investments | 1.09B | 1.09B | 1.09B | 1.09B | 1.09B |
| Goodwill | 1.09B | 1.09B | 1.09B | 1.09B | 1.09B |
| Total Other Intangibles | 424.20M | 429.80M | 435.50M | 441.20M | 825.90M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.05B | 3.95B | 3.72B | 3.49B | 3.27B |
| Total Assets | 25.64B | 24.86B | 24.04B | 22.88B | 22.53B |
|
|
|||||
| Total Accounts Payable | 461.70M | 420.30M | 442.30M | 445.00M | 413.00M |
| Total Accrued Expenses | 2.87B | 3.61B | 3.27B | 2.95B | 2.63B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 82.80M | -- | -- | -- | 92.30M |
| Total Finance Division Other Current Liabilities | 448.60M | 441.50M | 425.40M | 386.40M | 431.80M |
| Total Other Current Liabilities | 448.60M | 441.50M | 425.40M | 386.40M | 431.80M |
| Total Current Liabilities | 3.86B | 4.48B | 4.14B | 3.78B | 3.56B |
|
|
|||||
| Total Current Liabilities | 3.86B | 4.48B | 4.14B | 3.78B | 3.56B |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.95B | 1.83B | 1.53B | 1.65B | 1.66B |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.16B | 1.23B | 1.20B | 951.90M | 901.80M |
| Total Liabilities | 6.98B | 7.54B | 6.86B | 6.38B | 6.12B |
|
|
|||||
| Common Stock & APIC | 5.12B | 5.01B | 5.99B | 6.18B | 6.68B |
| Retained Earnings | 13.56B | 12.37B | 11.29B | 10.25B | 9.61B |
| Treasury Stock & Other | -15.90M | -64.50M | -101.10M | 68.10M | 127.80M |
| Total Common Equity | 18.67B | 17.32B | 17.18B | 16.50B | 16.41B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 18.67B | 17.32B | 17.18B | 16.50B | 16.41B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 18.67B | 17.32B | 17.18B | 16.50B | 16.41B |
|
|
|||||